Video
Blockbuster Era May Be in Decline
But it's Not Over Yet
In this video, Senior Editor Ben Comer offers a preview of Pharm Exec's upcoming 2012 pipeline report, and reveals that many of this year's featured companies are still anticipating billion-dollar sales ...View the video
Advertisement
Measurement of case quality in pharmacovigilance is a relatively new development. Until pharmaceutical companies began outsourcing their case processing operations, the only measure of effectiveness of their internal operations was compliance with regulatory reporting timelines. Now that these operations are performed by vendors, over the last two years vendor management organizations within pharmaceutical companies and Health Authorities have come up with a way to measure the “quality” of Adverse Event (AE) cases. This paper captures our experience and learning in defining and using  Case Quality Metrics while working with large and small pharmaceutical companies.
Contact Email:ask@sciformix.com |
Healthcare Reform
Dissecting ACA's Section 6004
With the Affordable Care Act officially settling into the US' political landscape, a pressing but little noticed issue is the provisions for increased compliance on industry promotion practices. Clark Herman reports
...Read More
R&D
Pharma in the Dell: Working with Academia
How can the emerging field of data science help to fruitfully translate research and discovery into successful drug development? Academics and pharmaceutical executives at Mount Sinai's School of Medicine discussed ways to build a bridge across the valley of death in R&D
...Read more
Advertisement
Pharmaceutical sales organizations navigate several challenges in today's dynamic markets: volatile sales portfolios, changing managed care contracts, and impaired physician access. Learn 4 key reasons why you need a dynamic alignment management system for today's marketplace.  Download today! |
Global
Pharma Throws Greece Another Lifeline. Will Greece Reciprocate?
Although it took its part yesterday in the latest widespread strikes against austerity measures that swept across Europe, Greece has been thrown a couple more lifelines not least by the European Federation of Pharmaceutical Industries and Associations (EFPIA)
...Read more
Advertisement
Global Launch in a Post-Blockbuster Era
What Life Science Companies Need to Know
Read insights, strategies and best practices from Advanstar's award-winning Pharmaceutical Executive magazine and IMS Health designed especially for industry executives, brand teams, and product managers to help them successfully launch their brands in a new and highly competitive global post-blockbuster era.  Click Here |
Regulatory
FDA Already Knew of Problems at New England Compounding Center
In the wake of the meningitis outbreak caused by contaminated compounded medications produced by the New England Compounding Center (NECC), both the government and the public have been wrestling with the question of how this happened how did a company producing substandard medicines slip through regulatory oversight?
...Read more
Drug Launch
Why Do So Many New Drugs End Up as Launch Failures?
Pharm Exec's new iPad-ready eBook, Global Launch in a Post-blockbuster Era, is available for download now
...Read more
Advertisement
Next Generation Informatics Needs for Pharma
Live Webcast: Thursday, November 15, 2012 at 2:00 PM Eastern Time
Register Free at  www.pharmexec.com/informatics |
|
